Exploring the wider societal impacts of sexual health issues and interventions to build a framework for research and policy: a qualitative study based on in-depth semi-structured interviews with experts in OECD member countriesLena Schnitzler, Aggie T G Paulus, Tracy E Roberts, Silvia M A A Evers, Louise J Jackson
12 January 2023
Correlation between the ratio of physician consultation fees to hourly minimum wage and consultation length: a cross-sectional study of nine countriesJu-Ryoung Kim, Se-Jin Byun, Dae-Soon Son, Hyun Ah Kim
22 December 2022
Impact of community-based health insurance on healthcare utilisation and out-of-pocket expenditures for the poor in SenegalMamadou Selly Ly, Adama Faye, Mouhamadou Faly Ba
20 December 2022
Real price of health-experiences of out-of-pocket costs in Australia: protocol for a systematic reviewShelley Ting-Li Wang, Anne Parkinson, Danielle Butler, Hsei Di Law, Vanessa Fanning, Jane Desborough
20 December 2022
Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019Min Li, Na Zhou, Shengnan Duan, Hua Zhong, Rong Jiang, Ni Yuan
8 December 2022
Developing and testing unconditional cash transfer strategies among young adults with first-episode psychosis in South Africa: a study protocol for a pilot randomised control trial (PRS-FEP trial)Joyce Protas Mlay, Lise Jamieson, Vuyokazi Ntlantsana, Thirusha Naidu, Busisiwe Siphumelele Bhengu, Saeeda Paruk, Jonathan K Burns, Bonginkosi Chiliza, Richard Lessells, Andrew Tomita
5 December 2022
Impact of conditional cash transfer programmes on antenatal care service uptake in low and middle-income countries: a systematic reviewWard Jacobs, Laura Emily Downey
25 November 2022
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trialJean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll, Dan Howard, Andy Buckland, Marine Sivignon, Emilie Clay, David Malka, Emmanuelle Samalin, Mondher Toumi, Philippe Laramée
21 November 2022
Neratinib plus capecitabine versus lapatinib plus capecitabine as the third-line therapy for HER2-positive metastatic breast cancer in China: a cost-effectiveness analysisYue Wu, Zhu Dong, Jiangfeng Wang, Qingxia Fang
15 November 2022
Economic evaluation of FLOT and ECF/ECX perioperative chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinomaHanqing Zeng, Chunjiang Wang, Li-Ying Song, Su-Jie Jia, Xiaohui Zeng, Qiao Liu
14 November 2022